China Universal Asset Management Co., Ltd. Crispr Therapeutics Ag Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 17,205 shares of CRSP stock, worth $743,083. This represents 0.06% of its overall portfolio holdings.
Number of Shares
17,205
Previous 18,098
4.93%
Holding current value
$743,083
Previous $712,000
17.84%
% of portfolio
0.06%
Previous 0.07%
Shares
17 transactions
Others Institutions Holding CRSP
# of Institutions
480Shares Held
64.2MCall Options Held
2.15MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$439 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$262 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$164 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$120 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.54MShares$110 Million1.16% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.37B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....